French pharmaceutical group Sanofi-Aventis has completed its acquisition of 100% of Chattem, a US-based provider of branded over-the-counter healthcare products, toiletries and dietary supplements, which is now a wholly owned subsidiary of the Sanofi-Aventis Group.
118945
Sanofi-Aventis completes acquisition of Chattem
124550
Viewpointe completes acquisition of PaymentsNation
38003
ConvaTec completes acquisition of Unomedical
61733
Audax Group announces the acquisition
49049
Zui acquired by Saban Brands
106973
Questcor Pharmaceuticals acquires rights to Synacthen®
115259
Sanofi-aventis extends tender offer for all outstanding shares of Genzyme
81028
Arkema announces the acquisition by
91902
Pfizer buys rival drugmaker Wyeth for $68 billion
77532
Astellas Pharma to acquire OSI Pharmaceuticals
79889
Merck buys drug rival Schering-Plough
53804
Covidien announces definitive agreement to acquire Aspect Medical Systems, Inc.
72886
Gilead Sciences completes acquisition of YM BioSciences
7601
Sanofi extends bid for Genzyme
79421
Medfusion acquires Medem's iHealth services
34605
Eli Lilly acquires SGX Pharmaceuticals
61307
Advantest's terahertz spectroscopic/imaging system TAS7500 adopted by Astellas Pharma Inc.